basal insulin and glp 1 Let's compare GLP-1 agonists! 💊 GLP-1 agonists have many benefits over basal insulin in patients with type 2 diabetes. GLP-1 agonists can be dosed as weekly injections instead of Frontiers | GLP-1R in diabetes

We advocate for diabetes patients needing access to programs calculating medication costs using financial circumstances rather than insurance formulary tiers

Individuals with a family history of diabetes are also at higher risk

Qsymia is not a GLP-1

By mimicking these hormones, the drug does the following: Increases insulin secretion, resulting in lower blood sugar Decreases glucagon production (For those with diabetes, unchecked glucagon production can result in blood sugars that are too high.) Slows gastric emptying (process by which the contents of the stomach are emptied into the duodenum, the first part of the small intestine)

doi: 10.4183/aeb.2022.216